Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Notice of Proposed Sale · 144

Monopar Therapeutics Inc.

MNPRNASDAQEQUITYCurrent

Notice of Proposed Sale

Filed Aug 25, 2026Accepted Aug 25, 2026, 4:44 PM EDTFiling CIK 1362489Accession 0001950047-26-008691
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
MONOPAR THERAPEUTICS INC.
Issuer CIK
0001645469
SEC file number
001-39070
Phone
847-388-0349
Person for whose account securities are to be sold
RAYMOND WILLIAM ANDERSON
Relationships to issuer
Director
Street
1000 Skokie Blvd., Suite 350
City
Wilmette
State / country code
IL
Postal code
60091

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Common6,284699,786.246,712,17208/25/2026NASDAQMorgan Stanley Smith Barney LLC Executive Financial Services

Broker / market maker — proposed row 1, entry 1

Name
Morgan Stanley Smith Barney LLC Executive Financial Services
Street
1 New York Plaza
Street (continued)
8th Floor
City
New York
State / country code
NY
Postal code
10004

Acquisition of securities to be sold

Acquisition of securities to be sold · 1 reported row
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Common08/25/2026Exercise of Stock OptionsIssuer6,284N08/25/2026Cash

Prior-sale reporting

Nothing to report for the preceding three months
Y

Remarks

The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.

Notice signature

Notice date
08/25/2026
Signed
/s/ Raymond William Anderson
Plan adoption dates
05/26/2026

Company context

Current securities

Recent company filings

  1. 4 filingOct 5, 2026
  2. 144 filingOct 1, 2026
  3. 4/A filingAug 28, 2026
  4. 4/A filingAug 28, 2026
  5. 4 filingAug 27, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.